Biosynthetic studies on the α-glucosidase inhibitor acarbose in Actinoplanes sp.:: 2-epi-5-epi-valiolone is the direct precursor of the valienamine moiety

被引:56
作者
Mahmud, T [1 ]
Tornus, I [1 ]
Egelkrout, E [1 ]
Wolf, E [1 ]
Uy, C [1 ]
Floss, HG [1 ]
Lee, S [1 ]
机构
[1] Univ Washington, Dept Chem, Seattle, WA 98195 USA
关键词
D O I
10.1021/ja991102w
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The biosynthetic pathway leading to the mC(7)N cyclitol (valienamine) moiety of acarbose (1) in Actinoplanes sp. strain SN 223/29 has been studied using H-3-, H-2-, and C-13-labeled cyclitols. These precursors were synthesized from D-glucose or D-mannose as starting materials. The feeding experiments demonstrated that cyclitols having the same stereochemistry at C-2 as the valienamine moiety of acarbose; i.e., valienone, valienamine, valiolone, valiolamine, and 1-epi-valienol, were not incorporated and thus are not plausible intermediates in 1 biosynthesis. 2-epi-Valiolone (10b), which has the same stereochemistry as the presumed open-chain precursor, sedoheptulose 7-phosphate, was also not incorporated. However, its C-5 epimer (10a) was incorporated efficiently and specifically into the valienamine moiety of 1. Surprisingly, the dehydrated form of 2-epi-5-epi-valiolone, 2-epi-valienone, was not incorporated. This suggests that 2-epi-5-epi-valiolone must be converted directly into the pseudodisaccharide moiety of acarbose without the intervention of other free cyclitol intermediates. This may occur by linkage to the amino group of TDP-4-amino-4,6-dideoxyglucose to form. the imine, epimerization at C-2 to the correct stereochemistry, dehydration between C-5 and C-6 aided by enamine formation, and finally reduction to the amine. It is proposed that these reaction steps all take place on a single enzyme without free intermediates. Alternative mechanistic possibilities are also discussed.
引用
收藏
页码:6973 / 6983
页数:11
相关论文
共 29 条
[1]   BIOSYNTHESIS OF THE MITOMYCIN ANTIBIOTICS FROM 3-AMINO-5-HYDROXYBENZOIC ACID [J].
ANDERSON, MG ;
KIBBY, JJ ;
RICKARDS, RW ;
ROTHSCHILD, JM .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1980, (24) :1277-1278
[2]  
BACH G, 1993, LIEBIGS ANN CHEM, P241
[3]   THE SOLUTION CONFORMATION OF ACARBOSE [J].
BOCK, K ;
PEDERSEN, H .
CARBOHYDRATE RESEARCH, 1984, 132 (01) :142-149
[4]   STUDIES ON THE BIOSYNTHESIS OF THE ALPHA-GLUCOSIDASE INHIBITOR ACARBOSE - VALIENAMINE, A M-C7N UNIT NOT DERIVED FROM THE SHIKIMATE PATHWAY [J].
DEGWERT, U ;
VANHULST, R ;
PAPE, H ;
HERROLD, RE ;
BEALE, JM ;
KELLER, PJ ;
LEE, JP ;
FLOSS, HG .
JOURNAL OF ANTIBIOTICS, 1987, 40 (06) :855-861
[5]  
DONG H, 1998, THESIS U WASHINGTON
[6]   Natural products derived from unusual variants of the shikimate pathway [J].
Floss, HG .
NATURAL PRODUCT REPORTS, 1997, 14 (05) :433-452
[7]   SYNTHESIS OF A BRANCHED-CHAIN INOSOSE DERIVATIVE, A VERSATILE SYNTHON OF N-SUBSTITUTED VALIOLAMINE DERIVATIVES FROM D-GLUCOSE [J].
FUKASE, H ;
HORII, S .
JOURNAL OF ORGANIC CHEMISTRY, 1992, 57 (13) :3642-3650
[8]   REVISED PATHWAY FOR THE BIOSYNTHESIS OF ARISTEROMYCIN AND NEPLANOCIN A FROM D-GLUCOSE IN STREPTOMYCES CITRICOLOR [J].
HILL, JM ;
JENKINS, GN ;
RUSH, CP ;
TURNER, NJ ;
WILLETTS, AJ ;
BUSS, AD ;
DAWSON, MJ ;
RUDD, BAM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (19) :5391-5392
[9]  
Iwasa T., 1970, J. Antibiot, V23, P595, DOI [10.7164/antibiotics.23.595, DOI 10.7164/ANTIBIOTICS.23.595]
[10]  
KAMEDA Y, 1984, J ANTIBIOT, V37, P1301, DOI 10.7164/antibiotics.37.1301